Cambia FDA Approval History
FDA Approved: Yes (First approved June 17, 2009)
Brand name: Cambia
Generic name: diclofenac potassium
Dosage form: for Oral Solution
Previous Name: PRO-513
Company: Kowa Pharmaceuticals America, Inc.
Treatment for: Migraine, Chronic Migraine
Cambia (diclofenac potassium) is a non-steroidal anti-inflammatory drug combined with potassium bicarbonate for the treatment of acute migraine with or without aura in adults.
Development Timeline for Cambia
|Jun 23, 2009||ApprovalFDA Approves Cambia for Migraine|
|Dec 12, 2007||ProEthic Pharmaceuticals Announces Acceptance of PRO-513 New Drug Application for Migraine|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.